MANILA, Philippines — The National Task Force (NTF) Against COVID-19 expressed confidence that the Philippines has a month’s supply of COVID-19 vaccines at present.
In its post, the NTF reported a stockpile of 12,826,099 doses of anti-COVID-19 vaccines in total as of Wednesday (July 21) which will be sufficient to meet the country’s vaccination needs for more than a month.
According to NTF chief implementer and vaccine czar Secretary Carlito G. Galvez Jr, the national government has in fact exceeded its target of having at least 10 million doses for its supply inventory.
“Sa ngayon po sumobra pa po tayo na 12,826,099 in which our supply can last up to 32 days or up to August 17,” Galvez said in his report during President Rodrigo Duterte’s Talk to the People address on Monday, July 19.
“Kampante po tayo na sa August 17 ay hindi po tayo mahihirapan [at hindi] na magkaroon ng shortage,” he added.
Galvez said the country received its largest vaccine delivery last week totaling 7,142,450 doses from various manufacturers.
He added that the country is expecting an additional 9,353,340 shots until the end of July.
“Dati po tinatanong niyo po ako kung anong state ng stockpile. Tayo medyo maganda na po ang ating [stockpile] — hindi na po tayo kakaba-kaba,” Galvez added.
To date, Galvez said a total of 27,922,360 vaccine doses have been delivered to the country since February broken down as follows:
Government procured: 15,501,200 doses
13,500,000 Sinovac doses
1,150,800 AstraZeneca doses
500,400 Moderna doses
350,000 Sputnik V doses
Delivered by the WHO-led COVAX facility: 10,297,060 doses
4,584,000 AstraZeneca doses
3,240,850 Johnson & Johnson doses
2,472,210 Pfizer doses
From Foreign Donations: 2,124,100 doses
1 million Sinovac doses from the Chinese government
1,124,100 AstraZeneca doses from the Japanese government
All in all, Galvez said the country aims to secure a total of 164 million vaccine doses consisting of shots procured by the government, as well as those coming from the COVAX facility and various donor countries.